Allergy Immunotherapy, a Preventive Treatment for Allergic Reactions

 

Allergy Immunotherapy is a medical therapy for seasonal allergic reactions, such as pollen and dust mites. It is also effective in treating serious allergens such as tree sap, mold, mold spores, animal dander, and other substances that can trigger an allergic reaction in allergy sufferers. Allergic asthma is a chronic condition and if not managed properly can lead to death. Allergic Asthma Therapeutics is designed to target the specific allergen that can cause problems and thus, makes it easier to manage asthma attacks.

Allergy immunotherapy involves exposing individuals to larger doses of the allergic substance to alter the body's response to that allergen. The treatment can be given in the form of injections, patches, or oral medication. A patch is used by placing a small amount of the allergenic substance on the skin to provide a temporary barrier to the allergenic substance and in the oral medication, the allergenic substance is taken orally and the body is exposed to the allergen repeatedly. This process allows the body to develop a tolerance for the allergen. There are several benefits of this therapy, including relief from seasonal allergies that can lead to more serious diseases such as allergic rhinitis and asthma. Moreover, three main types of allergy immunotherapy are currently in use, such as oral allergy immunotherapy, subcutaneous allergy immunotherapy (SCIT), and sublingual allergy immunotherapy (SLIT). Of these, SLIT treats allergies with tablets rather than injections.

Allergic rhinitis and asthma are some of the most common inhaled allergies that affect the majority of the population across the globe. For instance, According to the Centers for Disease Control and Prevention (CDC), more than 25 million Americans have asthma. Moreover, according to the European Academy of Allergy and Clinical Immunology, over 150 million Europeans suffer from chronic allergic diseases and around 50% of Europeans are expected to have at least one form of allergy by 2025.


Comments